Log In
Tuesday 20th March 2018

Cancer hotspots pinpointed

3rd April 2013

A study funded by the Wellcome Trust and Cancer Research UK has discovered over 80 regions of the genome that can heighten a person's danger of developing prostate, breast and ovarian cancer.


The Collaborative Oncological Gene-environment Study (COGS) research is headed by scientists at the University of Cambridge and The Institute of Cancer Research, London.

The researchers, who studied 100,000 people with cancer and 100,000 people "from the general population", looked for genetic variations which were more prevalent in people with breast, ovarian or prostate cancer.

Professor Doug Easton, a Cancer Research UK scientist at the University of Cambridge and the study's author, said: "We're on the verge of being able to use our knowledge of these genetic variations to develop tests that could complement breast cancer screening and take us a step closer to having an effective prostate cancer screening programme."

"By looking for people who carry most of these variations, we will be able to identify those who are at the greatest risk of getting these cancers and then targeting screening tests to these individuals."

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Cancer hotspots pinpointed
Author: Jess Laurence
Article Id: 23965
Date Added: 3rd Apr 2013



Recent Related Articles

Obesity can lead to certain cancers

Pfizer pulls out of Alzheimer's research


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018